How NMI Uses xMAP Technology to Help Differentiate From Other Biomarker Testing Service Providers

Luminex Corporation develops, manufactures, and sells proprietary technology, assays, and systems that empower labs to obtain reliable, timely, and actionable answers, ultimately advancing health. Our Molecular Diagnostics (MDx) and Life Science and Clinical Tools portfolios provide cost-effective, flexible solutions for hospitals, reference labs, and researchers, as well as innovative xMAP^® and flow cytometry solutions that span a wide variety of applications, including molecular diagnostics, drug discovery, life science research, immunology, personalized medicine, cellular analysis, and more. Our goal is to transform global healthcare with innovative technology that delivers rapid, reliable results to clinicians and researchers. Most recently, we have been actively focused on providing diagnostic tests for SARS-CoV-2, with two diagnostic tests currently on the market. We are also pursuing several additional options in serology testing. For further information, please visit luminexcorp.com/.